SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-09-003942
Filing Date
2009-04-08
Accepted
2009-04-08 08:05:02
Documents
6
Period of Report
2009-05-14
Effectiveness Date
2009-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2191910zdef14a.htm DEF 14A 1652874
3 G701603.JPG g701603.jpg GRAPHIC 13485
4 G234598.JPG g234598.jpg GRAPHIC 6110
5 G600506.JPG g600506.jpg GRAPHIC 8685
6 G21712BCI001.JPG g21712bci001.jpg GRAPHIC 3561
7 G21712BCI002.JPG g21712bci002.jpg GRAPHIC 3585
  Complete submission text file 0001047469-09-003942.txt   1703746
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19319 | Film No.: 09738791
SIC: 2834 Pharmaceutical Preparations